Antimicrobial Resistance Ignited by COVID-19 Pandemic: SOS for Antimicrobial Stewardship

Antimicrobial resistance (AMR) is a serious global danger to human health. The COVID-19 (coronavirus disease 2019) pandemic has sparked interest in studying both the consequences of such medical catastrophes on our environment and the techno-economic crisis they have brought about. Unusual situations frequently necessitate extraordinary responses. AMR to currently available frontline medications may prove lethal and life-threatening for bacterial and fungal diseases under the cover of the present epidemic. Currently, a swift elevation in multidrug-resistant organisms, like carbapenem-resistant New Delhi metallo-ß-lactamase-producing Enterobacterales, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus, extended-spectrum ß-lactamase producing Klebsiella pneumoniae, pan-echinocandin-resistant Candida glabrata, and multi-triazole-resistant Aspergillus fumigatus, has been seen. The purpose of this chapter is to emphasize several aspects of AMR, including its incidence and persistence in the environment, the co-occurrence and recurrence of illnesses associated with AMR in COVID cases, the handling of the COVID-19 crisis, and the lessons learnt from the pandemic for AMR stewardship. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2023.

Antimicrobial Resistance Ignited by COVID-19 Pandemic: SOS for Antimicrobial Stewardship Chapter in Scopus